Che Jie, Zhang Hong-Bin, Guo Ying-Hui, Jia Zhao-Yi, He Bao-Hua, Chen Bo-Han, Shao Zhu-Jun, Sun Yin-Qi, Li Qi
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Hebei Province Center for Disease Control and Prevention Bacterial Disease Prevention and Disinfection Institute, Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, Shijiazhuang, 050021, China.
BMC Infect Dis. 2025 Sep 26;25(1):1144. doi: 10.1186/s12879-025-11396-2.
The introduction of the Haemophilus influenzae type b (Hib) vaccine has led to significant variations in the epidemiological patterns of H.influenzae globally, with regional differences. However, large sample pathogenetic studies and comparative analyses of H.influenzae in China remain limited, especially in Hebei Province. This study aimed to characterize the patterns in serotypes and the antimicrobial resistance of invasive and non-invasive H.influenzae in children under 14 years of age in Hebei Province.
An observational study was conducted from January 2019 to December 2021 at Hebei Children's Hospital. H.influenzae was identified using classical biochemical methods, MALDI-TOF MS and hpd gene-based qPCR. Slide agglutination serotyping and molecular capsular typing determined the capsular types. Antimicrobial resistance was tested with the broth dilution method and Kirby-Bauer disk diffusion method, and β-lactamase production was detected using nitrocefin disks.
Among 241 H.influenzae isolates, 13 were invasive and 228 were non-invasive. The proportion of invasive isolates differed significantly across age groups (P = 0.005), i.e., 14.55% among patients < 1 year of age, 0.00% among 1-2 years of age, 4.26% among 3-5 years of age, and 2.33% in the 6-13 age groups. Three capsular types were detected: Hib (10/241), Hie (2/241), and Hif (7/241), with 222 isolates identified as NTHi. Hib accounted for 61.54% of the invasive isolate. Antimicrobial susceptibility tests also showed that invasive isolates exhibited higher nonsensitivity to cefuroxime, ceftriaxone, cefepime, imipenem, meropenem, and clarithromycin compared to non-invasive isolates (P < 0.05). The percentage of BLNAI and BLNAR was also higher for invasive isolates than in non-invasive ones (46.15% vs. 20.61%, P = 0.042).
Although NTHi is becoming the predominant pathogen of H.influenzae infection in children under 14 years, Hib remains the leading cause of invasive infection in Hebei Province. The high prevalence of β-lactamase-producing and BLNAR isolates underscores a growing challenge in antimicrobial resistance, particularly among invasive isolates.
b型流感嗜血杆菌(Hib)疫苗的引入导致全球流感嗜血杆菌的流行病学模式出现显著差异,存在地区差异。然而,中国关于流感嗜血杆菌的大样本病原学研究和比较分析仍然有限,尤其是在河北省。本研究旨在描述河北省14岁以下儿童侵袭性和非侵袭性流感嗜血杆菌的血清型模式及抗菌药物耐药性。
2019年1月至2021年12月在河北省儿童医院进行了一项观察性研究。采用经典生化方法、基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)和基于hpd基因的定量聚合酶链反应(qPCR)鉴定流感嗜血杆菌。通过玻片凝集血清分型和分子荚膜分型确定荚膜类型。采用肉汤稀释法和 Kirby-Bauer 纸片扩散法检测抗菌药物耐药性,使用头孢硝噻吩纸片检测β-内酰胺酶的产生。
在241株流感嗜血杆菌分离株中,13株为侵袭性,228株为非侵袭性。侵袭性分离株的比例在各年龄组之间存在显著差异(P = 0.005),即1岁以下患者中为14.55%,1-2岁患者中为0.00%,3-5岁患者中为4.26%,6-13岁年龄组中为2.33%。检测到三种荚膜类型:Hib(10/241)、Hie(2/241)和Hif(7/241),222株分离株鉴定为非b型流感嗜血杆菌(NTHi)。Hib占侵袭性分离株的61.54%。抗菌药物敏感性试验还表明,与非侵袭性分离株相比,侵袭性分离株对头孢呋辛、头孢曲松、头孢吡肟、亚胺培南、美罗培南和克拉霉素的不敏感性更高(P < 0.05)。侵袭性分离株中β-内酰胺酶非产酶耐药(BLNAI)和β-内酰胺酶耐药(BLNAR)的百分比也高于非侵袭性分离株(46.15% 对 20.61%,P = 0.042)。
虽然NTHi正成为14岁以下儿童流感嗜血杆菌感染的主要病原体,但Hib仍然是河北省侵袭性感染的主要原因。产β-内酰胺酶和BLNAR分离株的高流行率凸显了抗菌药物耐药性方面日益严峻的挑战,尤其是在侵袭性分离株中。